CGM and FreeStyle Libre evaluation | 1 December 2018 Changes to the NDSS Product Schedule | User research for NDSS Online Services Portal | Changes to the NDSS from 1 July 2016 | Overview | Access Points | Registrants | Products
Continuous Glucose Monitoring and FreeStyle Libre flash glucose monitoring
On 25 November 2018, the Minister for Health, the Hon Greg Hunt MP, announced that the Liberal National Government would commit more than $100 million in additional funding to expand the Continuous Glucose Monitoring (CGM) Initiative.
Further information can be found on the Continuous Glucose Monitoring page.
From 1 December 2018, there will be changes to the brands of some products available on the NDSS Product Schedule, however, people registered with the NDSS will still be able to access the products they need.
More than 95 per cent of people with diabetes registered with the NDSS will not be affected by these product changes.
Most people who access subsidised products through the NDSS will receive a reduction in the co-payment they pay. There are no increases to the cost of products and no new restrictions to accessing products.
These changes are part of the Australian Government’s commitment to supporting people with diabetes to self-manage their condition, and to ensure the NDSS can meet the needs of people with diabetes in the long term.
The Department of Health undertook a review of products subsidised under the NDSS. Information was gathered from product vendors and relevant clinical experts, and the following product categories were reviewed:
- blood glucose test strips;
- urine ketone test strips; and
- insulin syringes.
Where a person is required to change their current brand of blood glucose test strip, a clinically equivalent alternative will be available to them on the revised NDSS Product Schedule. In addition, people needing to change their current brand of blood glucose test strips under the new supply arrangements will be able to access a free blood glucose testing meter to use with their choice of new product.
Based on clinical advice, 13mm and 12.7mm syringes will no longer be available under the NDSS. Both 8mm and 6mm syringes will continue to be subsidised under the scheme.
Further advice about the changes, including fact sheets, information about co-payment changes and answers to common questions, can be found on the NDSS website, or by calling the NDSS Helpline on 1300 136 588.
Each year, Diabetes Australia undertakes registrant research to measure satisfaction levels of NDSS services. This research will commence in March 2018. It will include some questions about Registrants views on the creation of a centralised NDSS online services portal. The NDSS online services portal would:
- simplify NDSS registration for those newly diagnosed with diabetes;
- allow users to update contact details;
- provide online access to webinars and training courses; and
- offer information and notifications on changes to the NDSS.
If you have any questions about the NDSS online services portal or want to be involved in further user research, please email the NDSS team.
Frequently Asked Questions regarding the NDSS Request for Proposal Process
- FAQ - NDSS Request for Proposal Process (PDF 230 KB)
- FAQ - NDSS Request for Proposal Process (Word 24 KB)
There are no changes to the cost or types of products available under the NDSS, but the way you access these products may have changed. You can still access NDSS products through your local participating NDSS community pharmacy. At present there are over 5,000 community pharmacies which are NDSS Access Points across Australia. You can find your nearest NDSS pharmacy by calling the NDSS Helpline on 1300 136 588, or by using the online locator tool at http://osd.ndss.com.au/search/.
Diabetes Australia, and its state and territory agents, continue to provide education, support and advice to NDSS registrants over the phone and through ongoing education services. This includes training for NDSS community pharmacies on ordering and supplying NDSS products, including insulin pump consumables.
What are the changes from 1 July 2016?
- People with diabetes can still access NDSS products such as needles, syringes, blood glucose test strips and urine test strips from NDSS community pharmacies. In addition, since 1 July 2016 insulin pump consumables are available from NDSS community pharmacies. Where a pharmacy does not stock the insulin pump consumables required, they can be ordered by the pharmacy and delivered to the pharmacy generally within 24 hours.
- The range of products available has not changed.
- NDSS products are no longer available from Diabetes Australia or local state and territory diabetes organisations (this includes via state and territory diabetes organisation shops and websites, and the NDSS 1300 number).
- NDSS products are supplied to NDSS community pharmacies using the same distribution network that pharmacies use to receive medicines. Aligning these delivery channels streamlines the way products are delivered to pharmacies.
Changes to Access to Blood Glucose Test Strips
Frequently Asked Questions (regarding changes to the NDSS)
- FAQs for NDSS Registrants (Word 38 KB)
FAQs for NDSS Registrants (PDF 93 KB)
FAQs for NDSS Access Points (Word 33 KB)
FAQs for NDSS Access Points (PDF 112 KB)
FAQs for Health Professionals (Word 37 KB)
FAQs for Health Professionals (PDF 99 KB)
Access to NDSS Products in Rural and Remote Areas (Word 32 KB)
Access to NDSS Products in Rural and Remote Areas (PDF 228 KB)
- Grant Guidelines for the administration and delivery of services for the NDSS (Word 75 KB)
- Grant Guidelines for the administration and delivery of services for the NDSS (PDF 198 KB)
Table 1 - The number of people registered on the NDSS for each financial year, and Australian Government expenditure.
|Financial Year||Persons||Australian Government expenditure|
Table 2 - The number of people registered on the National Gestational Diabetes Register for each financial year
|Financial Year||Persons||Australian Government expenditure|
RegistrantsTo register with the NDSS, applicants must be diagnosed with diabetes and hold or be eligible to hold a Medicare card and live in Australia. Sometimes visitors to Australia may be eligible through a Reciprocal Health Care Agreement with their home country.
The PBS also funds a number of medicines for persons with diabetes. Australian Government expenditure on these supplies through the PBS in 2015-16 was over $538 million.
ProductsThe NDSS continues to subsidise the cost of syringes and needles, blood glucose test strips, urine ketone test strips and insulin pump consumables. A detailed list of products available through the NDSS can be found on the NDSS website.
Annually, over 5 million products are provided to NDSS Registrants.
On average over 60% of Registrants access products to assist in the self-management of their diabetes each year.